Upgrade

XBiotech Inc.

XBIT

Last
$2.29
Day
+4.1%
1y
-15.4%
5y
-83.4%
52w
-36.0%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1131d
EMA 21
2.19
EMA 50
2.22
EMA 200
2.41
20d high
-1.3%
5y high
-86.6%
5y range
1th
Website · 87 employees · United States

Positions held

Your positions

XBIT isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-15
Hold
avoid
Signal
Strong Sell
Target
$2.27
Stop
$2.15
Stop distance
6.1%
Target vs last
-0.9%

Fundamentals

Market cap$67.07MEnterprise value-$42.45MTrailing P/E—Forward P/E16.92
PEG—Price / book0.52Beta0.80Dividend yield0.00%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE-29.9%ROA-19.3%Debt / equity—
Current ratio33.15Free cash flow-$28.50MAnalyst recommendationnoneMean target—
52w high$3.4452w low$2.09

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.0M$0.0M$0.0M$0.0M$0.0M—
Op margin——————
Net income-$6.7M-$5.5M-$26.9M-$6.0M-$1.8M—
Gross margin——————
Gross profit——————
Operating income-$6.1M-$6.3M-$29.8M-$6.0M-$6.3M—

Yearly (6y)

20252024202320222021
Revenue$0.0M$0.0M$0.0M$4.0M—
Op margin———-860.1%—
Net income-$45.5M-$38.5M-$24.6M-$32.9M—
Gross margin———83.8%—
Gross profit——$0.0M$3.4M$12.6M
Operating income-$55.7M-$42.5M-$37.5M-$34.5M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

XBIT · daily+0.9% over 13 sessions
Close EMA21 EMA50 EMA200
2.132.152.182.212.232026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$27M-$20M-$13M-$7M$0M0%5%10%2025-Q22025-Q32025-Q42026-Q12026-Q2